MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

People With Parkinson’s Disease and Care Partners Experience Costly Work Productivity Loss

I. Malaty, N. Boame, A. Parab, S. Wang, M. Shah, C. Yan, J. Jimenez-Shahed (Gainesville, USA)

Meeting: 2025 International Congress

Keywords: Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: To evaluate work productivity loss (WPL) and associated costs among people with newly diagnosed Parkinson’s Disease (nPD), advanced PD (aPD), and care partners (CP).

Background: PD imposes a significant economic burden on people with PD (PwP) and CP. There is a limited understanding of the impact of PD on WPL outcomes for people with advancing stages of PD.

Method: This retrospective, observational cohort study used data from the Merative™ MarketScan® Commercial Claims database linked to Health and Productivity Management (Jan 2017-Dec 2021). Actively employed adults (18-64 y) with worker benefits and a PD diagnosis (Dx, ICD-10 G20.xx) treated with ≥1 PD medication were included and categorized into 2 groups: nPD (incident users of PD treatment) and aPD (prevalent PD, newly initiated on Levodopa Equivalent Daily Dose ≥1000mg over 30 consecutive days). CP were spouses of individuals with nPD (CnPD) or aPD (CaPD), without a PD Dx, and actively employed with worker benefits. Work absenteeism (WA), short-term disability (StD), and long-term disability (LtD) were defined as annual (12-month post-index) and calculated into indirect costs per the 2023 US Bureau of Labor Statistics hourly wage rate.

Results: Of individuals with linked claims and worker benefits data, only 0.04% had a PD Dx (nPD=385, aPD=305, CnPD=210, CaPD=238). Mean age was similar across PwP and CP (55.6-56.2 y) with most employed full time (96.2-97.1%). Most PwP were male (≥76%) and roughly half of CP were female (≥48%). Overall, 9.5-11.5% of PwP and CP reported WA, 4.3-10.5% filed for StD, and 1.3-3.0% of PwP filed for LtD [Table 1]. In nPD and aPD cohorts, 9.9 and 10.5% claimed StD for a mean duration of 76.9 and 65.3 d, respectively. Nearly half of StD claims (≥43%) were due to PD with a mean duration of 99.8 and 84.7 d, respectively, approximately 37-50 d longer than non-PD specific reasons (53.1-52.6%). Mean indirect costs of StD related to PD were also near twice higher ($13,239-$15,605) than for non-PD specific reasons ($7,528-$8,030) for PwP. Similarly, over half of LtD claims (60.0-66.7%) were due to PD.

Conclusion: PwP and CP may experience WPL, commonly due to PD, which was a prevalent cause of disability leave resulting in considerable indirect costs in both early and advanced PD. This underscores the economic burden of PD on employment and highlights the need for strategies to support PwP and CP in navigating these health challenges.

Table 1

Table 1

To cite this abstract in AMA style:

I. Malaty, N. Boame, A. Parab, S. Wang, M. Shah, C. Yan, J. Jimenez-Shahed. People With Parkinson’s Disease and Care Partners Experience Costly Work Productivity Loss [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/people-with-parkinsons-disease-and-care-partners-experience-costly-work-productivity-loss/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/people-with-parkinsons-disease-and-care-partners-experience-costly-work-productivity-loss/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley